{"podcast":{"title":"The Energy Code","slug":"the-energy-code-2136601","podcast_index_feed_id":2136601,"rss_url":"https://feed.podbean.com/theenergycode/feed.xml","website_url":"https://feed.podbean.com/theenergycode/feed.xml","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/10635338/Energy_Code_Apple_Podcast_Cover_Final.jpg","author":"Dr. Mike Belkowski","episode_count":369,"summary":"The Red Light Report podcast is your number one source for all things red light therapy, hosted by Dr. Mike Belkowski, the founder and CEO of BioLight. Dr. Belkowski discusses the many health-related benefits of properly utilizing red light therapy and explores the best and most recent research related to photobiomodulation (ie, red light therapy). He will also be interviewing some of the most interesting and respected health, wellness, longevity and biohacking experts from around the world. Want to learn even more about red light therapy? Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight","last_synced_at":"2026-07-23T22:20:31.206492+00:00","page_url":"https://stenobird.com/podcast/the-energy-code-2136601"},"episode":{"title":"Cancer Isn’t Just Genetic — It’s Mitochondrial Network Warfare (Fission, Fusion, Metastasis + Drug Resistance)","slug":"cancer-isn-t-just-genetic-it-s-mitochondrial-network-warfare-fission-fusion-metastasis-drug-resistance","published_at":"2026-04-13T10:45:00+00:00","page_url":"https://stenobird.com/podcast/the-energy-code-2136601/cancer-isn-t-just-genetic-it-s-mitochondrial-network-warfare-fission-fusion-metastasis-drug-resistance","show_page_url":"https://stenobird.com/podcast/the-energy-code-2136601","url":"https://theenergycode.podbean.com/e/cancer-isn-t-just-genetic-%e2%80%94-it-s-mitochondrial-network-warfare-fission-fusion-metastasis-drug-resistance/","audio_url":"https://mcdn.podbean.com/mf/web/ey399phas8b5pstg/network_mixdown.mp3","summary":"Cancer is not merely a genetic or metabolic disease, but a systematic remodeling of the mitochondrial network to drive malignancy. Tumors hijack fission, fusion, and transport mechanisms to power proliferation, metastasis, and drug resistance.","meta_description":"Explore how cancer cells strategically remodel mitochondrial networks—through fission and fusion—to drive metastasis, drug resistance, and immune evasion.","key_points":["Main idea: Cancer is a disease of mitochondrial network remodeling, not just static energy production","Failure mode: Hyperactive fission (DRP1) and reduced fusion (MFN1/2) create fragmented networks that support tumor survival","Practical takeaway: Targeting mitochondrial fission or fusion can disrupt tumor proliferation and invasion","Complexity alert: The same mitochondrial mechanism can promote growth in one tumor type while driving resistance in another","Future direction: Effective therapy will likely require strategic combinations of fission inhibitors and metabolic or immune modulators"],"chapters":[{"start_ms":60000,"title":"The Shift to Mitochondrial Networks","summary":"Moving beyond the 'powerhouse' metaphor to view mitochondria as an active, dynamic network driving tumor behavior."},{"start_ms":180000,"title":"Systematic Distortion in Cancer","summary":"How the balance of fission, fusion, and mitophagy is intentionally disrupted to support malignancy."},{"start_ms":240000,"title":"The Role of DRP1 and Fission","summary":"The mechanics of DRP1-driven fission and its impact on mitochondrial fragmentation and cell survival."},{"start_ms":360000,"title":"Morphology vs. Metabolic Function","summary":"How cancer cells maintain high oxidative metabolism despite a structurally fragmented mitochondrial network."},{"start_ms":540000,"title":"Driving Proliferation and Apoptosis Resistance","summary":"How mitochondrial dynamics regulate cell division and help cancer cells bypass programmed cell death."},{"start_ms":720000,"title":"Mitochondria as Tools for Metastasis","summary":"The strategic redistribution of mitochondria to the leading edge of cells to power migration and invasion."},{"start_ms":840000,"title":"Drug Resistance and Immune Evasion","summary":"How mitochondrial remodeling enables resistance to chemotherapy and reshapes the immune microenvironment."},{"start_ms":1020000,"title":"Therapeutic Strategies and Precision Oncology","summary":"The potential for fission inhibitors and combination therapies, and the challenges of tumor heterogeneity."}],"topics":["Mitochondrial Dynamics","Cancer Biology","Metastasis","DRP1","Drug Resistance","Metabolic Reprogramming","Precision Oncology","Cell Signaling"],"duration_seconds":1358,"processing_state":"processed","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-energy-code-2136601/episodes/cancer-isn-t-just-genetic-it-s-mitochondrial-network-warfare-fission-fusion-metastasis-drug-resistance/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-energy-code-2136601/cancer-isn-t-just-genetic-it-s-mitochondrial-network-warfare-fission-fusion-metastasis-drug-resistance.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}